Strategic Research Agreement — Round 1
Funds investigator-led type 1 diabetes research partnerships across preclinical discovery, treatment, and translational priorities.
Breakthrough T1D's Strategic Research Agreement (SRA) program is the organisation's flagship investigator-initiated grant mechanism, designed as a cooperative research partnership between academic investigators and Breakthrough T1D scientists. Breakthrough T1D — formerly JDRF, rebranded in June 2024 — is a US 501(c)(3) nonprofit founded in 1970 that funds T1D research globally across five strategi…
Investigator-initiated type 1 diabetes research across all five Breakthrough T1D priority areas, structured as a cooperative milestone-based partnership with funder scientists.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline